UAMC-3203

CAS No. ——

UAMC-3203( UAMC3203 )

Catalog No. M17089 CAS No. ——

UAMC-3203 is a novel potent, drug-like ferroptosis inhibitor with IC50 of 12 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    UAMC-3203
  • Note
    Research use only, not for human use.
  • Brief Description
    UAMC-3203 is a novel potent, drug-like ferroptosis inhibitor with IC50 of 12 nM.
  • Description
    UAMC-3203 is a novel potent, drug-like ferroptosis inhibitor with IC50 of 12 nM, inhibit erastin-induced ferroptotic cell death more potently than Ferrostatin-1; shows an improved protection compared to Fer-1 against multi-organ injury in mice, represents novel lead compounds with therapeutic potential in relevant ferroptosis-driven disease models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    UAMC3203
  • Pathway
    Apoptosis
  • Target
    Ferroptosis
  • Recptor
    Ferroptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    508.122
  • Molecular Formula
    C25H38ClN5O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    3-(benzylamino)-4-(cyclohexylamino)-N-(2-(piperazin-1-yl)ethyl)benzenesulfonamide hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Devisscher L, et al. J Med Chem. 2018 Oct 25. doi: 10.1021/acs.jmedchem.8b01299.
molnova catalog
related products
  • FSEN1

    FSEN1 is a novel and highly effective non-competitive FSP1 inhibitor with an IC50 value of 313 nM.

  • UAMC-3203

    UAMC-3203 is a novel potent, drug-like ferroptosis inhibitor with IC50 of 12 nM.

  • PRLX-93936 HCL

    PRLX-93936 HCL is an analog of erastin and demonstrated synergistic effects against non-small cell lung cancer (NSCLC) cells with cisplatin.